Impedimed Total Cash From Operating Activities from 2010 to 2024

IPD Stock   0.05  0  2.00%   
Impedimed Total Cash From Operating Activities yearly trend continues to be comparatively stable with very little volatility. Total Cash From Operating Activities will likely drop to about -18.7 M in 2024. From the period from 2010 to 2024, Impedimed Total Cash From Operating Activities quarterly data regression had mean square error of 28.3 T and mean deviation of  5,034,881. View All Fundamentals
 
Total Cash From Operating Activities  
First Reported
2007-12-31
Previous Quarter
-6.8 M
Current Value
-11 M
Quarterly Volatility
3.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Impedimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Impedimed's main balance sheet or income statement drivers, such as Interest Expense of 88.3 K, Selling General Administrative of 23.2 M or Total Revenue of 5.2 M, as well as many indicators such as . Impedimed financial statements analysis is a perfect complement when working with Impedimed Valuation or Volatility modules.
  
This module can also supplement various Impedimed Technical models . Check out the analysis of Impedimed Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.